gvtcx

PHE - Corporate - UKNSC Non-Invasive Prenatal Testing

Public Health England Published 18 Jul 2019 Contracts Finder

key details

Statuscomplete
Category (CPV) 75122000
Deadline1 Mar 2019
Contract start1 Apr 2019
Contract end31 Mar 2020
Proceduredirect
SME suitableYes
OCIDocds-b5fd17-e3e5343f-c678-423b-ab8e-3903a6ba1862

Award

SupplierValueDateStatus
Warwick University £33,462 29 Mar 2019 active

description

The overall aim of the work is to apply the same methods used in a previous review, undertaken by Warwick University for the UK NSC, to review the evidence relating:

  1. the accuracy of a new version of the technology (microarray) which was not available at the time of the previous review. This will inform a decision on whether Fetal Anomaly Screening Programme should include microarray technology in future procurement work
  2. test accuracy for the detection T21, T18 and T13 in twins. At the time of the previous review there was insufficient evidence to make a recommendation in this area. This review aims to establish whether there is now sufficient evidence and to add the most recent evidence to that analysed in the previous review. This will include the older versions of the technology and micoarray technology.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
18 Jul 2019 Award (award) · e269050d-5058-4261-b16f-cc7f4de42466-302177

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.